Mr David F Jones > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices

Three Bryant Park, 1095 Avenue of the Americas
NY 10036-6797
United States
- Firm Profile
- Go to...
Mr David F Jones

Work Department
Employee Benefits and Executive Compensation
Position
Partner
Career
David F. Jones, co-chair of the employee benefits and executive compensation group, represents both public and private corporations, private equity investors, and hedge funds with respect to qualified and nonqualified retirement plans, as well as executive compensation and employee welfare benefit matters. Mr. Jones has done extensive work in dealing with the employee benefit aspects of mergers and acquisitions, representing both buyers and sellers. In addition, he assists clients with the integration and redesign of their employee benefit programs following significant acquisitions.
Mr. Jones has lectured on employee benefit matters at seminars and conferences sponsored by the Association of Corporate Counsel, the Practising Law Institute, the Pennsylvania-New Jersey-Delaware Employee Benefits Association, and the Strategic Research Institute.
Education
- Temple University, B.B.A., 1979, cum laude
- Temple University Beasley School of Law, J.D., 1982, cum laude, Business Editor of the Temple Law Review
- New York University School of Law, LL.M., 1984, in Taxation
Top Tier Firm Rankings
- Environment > Environment: transactional
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- International trade and national security > Customs, export controls and economic sanctions
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Healthcare > Life sciences
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending > Advice to direct lenders/private credit
- Dispute resolution > E-discovery
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > Financial services litigation
- Finance > Fintech
- Dispute resolution > International arbitration
- Tax > International tax
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)